TBPH
Theravance Biopharma Inc
Price:  
10.04 
USD
Volume:  
129,668.00
Cayman Islands | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TBPH WACC - Weighted Average Cost of Capital

The WACC of Theravance Biopharma Inc (TBPH) is 7.5%.

The Cost of Equity of Theravance Biopharma Inc (TBPH) is 7.70%.
The Cost of Debt of Theravance Biopharma Inc (TBPH) is 5.00%.

Range Selected
Cost of equity 5.90% - 9.50% 7.70%
Tax rate 1.30% - 2.40% 1.85%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.8% - 9.2% 7.5%
WACC

TBPH WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.43 0.82
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.90% 9.50%
Tax rate 1.30% 2.40%
Debt/Equity ratio 0.06 0.06
Cost of debt 5.00% 5.00%
After-tax WACC 5.8% 9.2%
Selected WACC 7.5%